Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The quick ratio (acid-test) is N/A as of Tuesday, October 6, 2026.
QUICK RATIO (ACID-TEST)
N/A
Market Cap
$229.78M
Quick Ratio (Acid-Test)
2.96
TTM Avg
4.42
3Y Avg
4.46
5Y Avg
4.62
Market Cap
$229.14M
Quick Ratio (Acid-Test)
2.85
TTM Avg
2.31
3Y Avg
2.01
5Y Avg
2.00
Market Cap
$229.12M
Quick Ratio (Acid-Test)
17.19
TTM Avg
13.55
3Y Avg
8.08
5Y Avg
8.08
Market Cap
$234.66M
Quick Ratio (Acid-Test)
10.14
TTM Avg
15.36
3Y Avg
19.42
5Y Avg
27.25
Market Cap
$234.54M
Quick Ratio (Acid-Test)
16.48
TTM Avg
8.13
3Y Avg
6.57
5Y Avg
7.38
Market Cap
$236.00M
Quick Ratio (Acid-Test)
44.27
TTM Avg
28.93
3Y Avg
23.00
5Y Avg
20.76
Market Cap
$236.58M
Quick Ratio (Acid-Test)
4.70
TTM Avg
7.13
3Y Avg
7.51
5Y Avg
5.59
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vogenx Inc. (VOGX) | $230.00M | N/A | N/A | N/A | N/A |
| MacroGenics, Inc. (MGNX)vs › | $229.78M | 2.96 | 4.42 | 4.46 | 4.62 |
| Biodesix, Inc. (BDSX)vs › | $229.14M | 2.85 | 2.31 | 2.01 | 2.00 |
| BioAge Labs Inc. (BIOA)vs › | $229.12M | 17.19 | 13.55 | 8.08 | 8.08 |
| Nautilus Biotechnolgy, Inc. (NAUT)vs › | $234.66M | 10.14 | 15.36 | 19.42 | 27.25 |
| SIGA Technologies, Inc. (SIGA)vs › | $234.54M | 16.48 | 8.13 | 6.57 | 7.38 |
| InflaRx N.V. (IFRX)vs › | $232.72M | 8.22 | 4.35 | 5.50 | 5.94 |
| Utah Medical Products, Inc. (UTMD)vs › | $236.00M | 44.27 | 28.93 | 23.00 | 20.76 |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $236.58M | 4.70 | 7.13 | 7.51 | 5.59 |
| Keros Therapeutics, Inc. (KROS)vs › | $222.36M | 21.96 | 18.45 | 17.11 | 21.15 |
Quick Ratio
N/A
Excludes inventory
Current Ratio
N/A
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
